Safety warnings on asthma drug

U.S. regulatory advisers on Wednesday recommended strengthening safety warnings on GlaxoSmithKline Plc's asthma drug Serevent amid new reports of deaths in children taking the drug.

The U.S. Food and Drug Administration expert panel on drugs for children reviewed nine new adverse event reports in kids taking the inhaled treatment, including five deaths over a period of about a year, among other studies finding increased hospitalization and asthma-related death in kids.




Al Jameela Polyclinic

New Kuwaity Building
Near Al-Futtaim Mosque,
Naif Road,Dubai

United Arab Emirates



For appointments / information

+971 50 550 4575

Zircon - This is a contributing Drupal Theme
Design by WeebPal.